What is the official website of The Center for Biosimilars ?

The official website of The Center for Biosimilars is http://www.centerforbiosimilars.com.

What is The Center for Biosimilars's cybersecurity risk score?

The Center for Biosimilars has an AI-generated cybersecurity risk score of 749 out of 1000, indicating a Moderate security posture according to Rankiteo's assessment.

How many security incidents has The Center for Biosimilars experienced?

According to Rankiteo, The Center for Biosimilars currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has The Center for Biosimilars been affected by any supply chain cyber incidents ?

According to Rankiteo, The Center for Biosimilars has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does The Center for Biosimilars have SOC 2 Type 1 certification ?

According to Rankiteo, The Center for Biosimilars is not certified under SOC 2 Type 1.

Does The Center for Biosimilars have SOC 2 Type 2 certification ?

According to Rankiteo, The Center for Biosimilars does not hold a SOC 2 Type 2 certification.

Does The Center for Biosimilars comply with GDPR ?

According to Rankiteo, The Center for Biosimilars is not listed as GDPR compliant.

Does The Center for Biosimilars have PCI DSS certification ?

According to Rankiteo, The Center for Biosimilars does not currently maintain PCI DSS compliance.

Does The Center for Biosimilars comply with HIPAA ?

According to Rankiteo, The Center for Biosimilars is not compliant with HIPAA regulations.

Does The Center for Biosimilars have ISO 27001 certification ?

According to Rankiteo,The Center for Biosimilars is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does The Center for Biosimilars operate in ?

The Center for Biosimilars operates primarily in the Book and Periodical Publishing industry.

How many employees does The Center for Biosimilars have ?

The Center for Biosimilars employs approximately 2 people worldwide.

Does The Center for Biosimilars own any subsidiaries ?

The Center for Biosimilars presently has no subsidiaries across any sectors.

How many LinkedIn followers does The Center for Biosimilars have ?

The Center for Biosimilars's official LinkedIn profile has approximately 17,537 followers.

What is the NAICS classification code for The Center for Biosimilars ?

The Center for Biosimilars is classified under the NAICS code 511, which corresponds to Publishing Industries (except Internet).

Does The Center for Biosimilars have a Crunchbase profile ?

No, The Center for Biosimilars does not have a profile on Crunchbase.

Does The Center for Biosimilars have a LinkedIn profile ?

Yes, The Center for Biosimilars maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/thecenterforbiosimilars.

How many cybersecurity incidents has The Center for Biosimilars experienced ?

As of July 7, 2026, Rankiteo reports that The Center for Biosimilars has experienced 2 cybersecurity incidents.

How many peer or competitor companies does The Center for Biosimilars have ?

The Center for Biosimilars has an estimated 5,133 peer or competitor companies worldwide.

What types of cybersecurity incidents has The Center for Biosimilars faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach and Cyber Attack.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Boost Score +25 with badge (5 left)

749

/1000

Moderate

774

/1000

Fair

The Center for Biosimilars Vendor Cyber Rating & Cyber Score

centerforbiosimilars.com

Add Your Compliance Badge

Health economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.

CB A.I CyberSecurity Scoring

Scoring History

The Center for Biosimilars CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

The Center for Bios...

Cyber Attack

08/2022

MJH018261022

The Center for Bios...

Breach

5/2018

PHA323072725

Loading…

A.I.

CB Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for CB

Incidents vs Book and Periodical Publishing Industry Avg (This Year)

No incidents recorded for The Center for Biosimilars in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for The Center for Biosimilars in 2026.

Incident Types CB vs Book and Periodical Publishing Industry Avg (This Year)

No incidents recorded for The Center for Biosimilars in 2026.

Incident History - CB (X = Date, Y = Severity)

Loading…

SUBSIDIARY

The Center for Biosimilars Subsidiaries

CB

Book and Periodical Publishing

Website: http://www.centerforbiosimilars.com

Company Size: 2-10 employees

MJH Life Sciences®Media Production

Pharmacy TimesBook and Periodical Publishing

Targeted OncologyOnline Audio and Video Media

Ophthalmology TimesMedia Production

Modern RetinaMedia Production

OncLiveBook and Periodical Publishing

Dermatology TimesBook and Periodical Publishing

Pharmaceutical ExecutiveBook and Periodical Publishing

dvm360®Veterinary Services

Applied Clinical Trials MagazineBook and Periodical Publishing

NeurologyLiveOnline Audio and Video Media

Pharmacy Benefit Management InstitutePharmaceutical Manufacturing

Association of Cancer Care CentersHospitals and Health Care

Institute for Clinical Immuno-Oncology (ICLIO)Hospitals and Health Care

LCGC InternationalBook and Periodical Publishing

Nutritional OutlookWellness and Fitness Services

Psychiatric TimesMedia Production

Turbomachinery InternationalBook and Periodical Publishing

Cancer NetworkBook and Periodical Publishing

Cannabis Science and TechnologyBook and Periodical Publishing

Drug TopicsBook and Periodical Publishing

Managed Healthcare ExecutiveMedia Production

Pharmaceutical TechnologyBook and Periodical Publishing

Urology TimesBook and Periodical Publishing

HCPLiveMedia Production

AJMC - The American Journal of Managed CareBook and Periodical Publishing

AJMC: Institute For Value Based MedicineHospitals and Health Care

AJMC: Center on Health Equity & AccessInternet News

Ophthalmology Times EuropeMedia Production

PER®Education Management

American Journal of Hematology / Oncology®Wellness and Fitness Services

Spectroscopy MediaBook and Periodical Publishing

Contagion_LiveBook and Periodical Publishing

Medical EconomicsBook and Periodical Publishing

Oncology Nursing NewsBook and Periodical Publishing

Physicians PracticeBook and Periodical Publishing

Dental Products ReportBook and Periodical Publishing

BioPharm InternationalBook and Periodical Publishing

Optometry TimesMedia Production

CMINon-profit Organizations

Cannabis Science ConferenceEvents Services

Specialty Pharmacy TimesMedia Production

FormularyWatchBook and Periodical Publishing

Contemporary OB/GYNBook and Periodical Publishing

CURE Media GroupBook and Periodical Publishing

Contemporary PediatricsBook and Periodical Publishing

Cannabis Patient CareBook and Periodical Publishing

MJH Thought LeadersMedia Production

Dental Lab ProductsBook and Periodical Publishing

Medical World NewsBroadcast Media Production and Distribution

Modern HygienistMedia Production

Total PharmacyBook and Periodical Publishing

meetmyMSLHospitals and Health Care

Infection Control Today®Online Audio and Video Media

Pharmacy Times Continuing Education™ (PTCE)Education Administration Programs

Pharmaceutical Commerce MagazinePharmaceutical Manufacturing

Diagnostic Imaging®Online Audio and Video Media

Loading…

The Center for Biosimilars Similar Companies

Forbes

forbes.com

Forbes Media is a global media, branding and technology company, with a focus on news and information about business, investing, technology, entrepreneurship, leadership and affluent lifestyles. The company publishes Forbes, Forbes Asia, and Forbes Europe magazines as well as Forbes.com. The Forbes brand today reaches more than 94 million people worldwide with its business message each month through its magazines and 37 licensed local editions around the globe, Forbes.com, TV, conferences, research, social and mobile platforms. Forbes Media’s brand extensions include conferences, real estate, education, financial services, and technology license agreements. Forbes is an equal opportunity employer.

Loading…

NEWS

The Center for Biosimilars CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

December 07, 2016 01:25 PM

Neal, Gerber & Eisenberg LLP - United States Firm

Read Neal, Gerber & Eisenberg LLP's United States profile to learn more about them and discover their Best Lawyers rankings.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-53646

SUMMARY

FOSSBilling is a free, open-source billing and client management system. In versions 0.5.6 through 0.7.2, when a `ClientPasswordReset` record already exists for a client (from a previous unexpired reset request), subsequent calls to the `reset_password` guest API endpoint reuse the existing token instead of generating a new one. The 15-minute validity window is anchored to the first request's `created_at` timestamp, not the time of the most recent email. An attacker who obtained the original reset link remains able to use it even after the victim requests a new reset, because the original token is never invalidated or rotated. Version 0.8.0 patches the issue. Some workarounds are available. Configure a reverse proxy (e.g., Nginx, Apache, Cloudflare) to apply per-IP rate limiting to the `/client/reset-password` endpoint to minimize the window of opportunity, and/or manually clear expired `client_password_reset` records from the database after a client reports a suspected compromise.

Published

Date2026-07-06

Updated

Date2026-07-06

RISK INFORMATION (Score: )

cvss4

Base Score: 7.7

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://github.com/FOSSBilling/FOSSBilling/security/advisories/GHSA-vp66-w6rc-x32p

CVE-2026-53645

SUMMARY

FOSSBilling is a free, open-source billing and client management system. Versions prior to 0.8.0 allow a low-privileged staff account to grant arbitrary module permissions to itself through the admin API, resulting in persistent privilege escalation. A staff user that only has `staff.create_and_edit_staff` can call `/api/admin/staff/permissions_update` targeting their own account and write any permission structure, bypassing the intended role-based access control boundary. Version 0.8.0 patches the issue. Some workarounds are available. Restrict the `staff.create_and_edit_staff` permission to only highly trusted staff members and/or use a reverse proxy or WAF to restrict access to `/api/admin/staff/permissions_update` to specific trusted roles.

Published

Date2026-07-06

Updated

Date2026-07-06

RISK INFORMATION (Score: )

cvss4

Base Score: 8.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:H/VA:N/SC:H/SI:H/SA:L/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://github.com/FOSSBilling/FOSSBilling/security/advisories/GHSA-4hf7-xxxw-64rm

CVE-2026-53644

SUMMARY

FOSSBilling is a free, open-source billing and client management system. Versions 0.5.3 through 0.7.2 allow authenticated clients to both read and reset API key service secrets for orders that are no longer in an `active` state (e.g., `suspended`, `canceled`). The root cause is missing order-state validation in two client API endpoints, despite an `isActive()` helper already existing in the `Serviceapikey` module and the frontend UI correctly gating access on `order.status == 'active'`. Version 0.8.0 contains a fix. Some workarounds are available. If the `Serviceapikey` module is not needed, uninstall it to remove the affected endpoints. One may also use a reverse proxy or WAF to restrict access to `/api/client/order/service` and `/api/client/serviceapikey/reset` based on application-level order-state logic.

Published

Date2026-07-06

Updated

Date2026-07-06

RISK INFORMATION (Score: )

cvss4

Base Score: 8.6

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://github.com/FOSSBilling/FOSSBilling/security/advisories/GHSA-qf6j-vq68-qmfh

CVE-2026-53643

SUMMARY

FOSSBilling is a free, open-source billing and client management system. Versions prior to 0.8.0 allow low-privileged staff accounts to perform unauthorized actions via admin API endpoints. The root cause is a combination of the `can_always_access` module flag (which grants all staff access to certain modules) and insufficient permission checks or unsafe parameter handling on individual endpoints. Version 0.8.0 contains a fix. Some workarounds are available. Restrict staff accounts to only those who need access to sensitive settings and/or use a reverse proxy or WAF to restrict access to the affected endpoints to trusted IP addresses or higher-privilege roles.

Published

Date2026-07-06

Updated

Date2026-07-06

RISK INFORMATION (Score: )

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://github.com/FOSSBilling/FOSSBilling/security/advisories/GHSA-563q-g4r4-6f9m

CVE-2026-53642

SUMMARY

FOSSBilling is a free, open-source billing and client management system. In versions 0.5.6 through 0.7.2, when the "Require Email Confirmation" setting is enabled, a logged-in client with an unverified email address (`email_approved = 0`) can access all client-area pages (e.g. `/client/balance`, `/client/order/list`, `/client/invoice`) and read real account data, including wallet balances and transaction history. The API-side enforcement correctly restricts unverified clients to only profile-related endpoints, but the page-side enforcement is overly permissive, allowing any request whose path starts with `/client`. Version 0.8.0 contains a fix. No known workarounds that don't involve modifying the source code are available.

Published

Date2026-07-06

Updated

Date2026-07-06

RISK INFORMATION (Score: )

cvss4

Base Score: 5.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://github.com/FOSSBilling/FOSSBilling/security/advisories/GHSA-7v47-rh46-w923

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…